What is a nabilone?
Nabilone
A synthetic cannabinoid (not plant-derived) licensed in the UK for chemotherapy-induced nausea and vomiting that has not responded to standard antiemetics. Available through oncology services.
Where you will see it
In the guides to NHS funding.
NHS and privateRelated terms
- CINV (Chemotherapy-Induced Nausea and Vomiting)
Nausea and vomiting caused by cancer chemotherapy. A well-evidenced indication for cannabinoid medicines including nabilone.
- Dravet Syndrome
A severe form of epilepsy beginning in infancy, associated with frequent and prolonged seizures. Epidyolex (CBD oral solution) is NICE-approved and NHS-funded for this condition.
- Epidyolex
A pharmaceutical-grade CBD oral solution. The only fully licensed cannabis-based medicine in the UK with NICE approval. Indicated for seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients aged 2 and above. NHS-funded.
- Lennox-Gastaut Syndrome (LGS)
A severe form of childhood-onset epilepsy characterised by multiple seizure types and intellectual disability. Epidyolex is NICE-approved and NHS-funded for this condition.
- Licensed Medicine
A medicine that has received a Marketing Authorisation from the MHRA following full clinical trials. Epidyolex, Sativex, and Nabilone are the only licensed cannabis-based medicines in the UK. Most CBPMs are prescribed as 'unlicensed specials'.
This is a plain-language definition for general understanding, not medical or legal advice.
All 101 terms